Onkure Therapeutics Inc (OKUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 124,660 | 126,409 | 140,368 | 91,221 | 53,613 |
| Marketable Securities | 23,010 | 31,325 | 26,963 | N/A | N/A |
| TOTAL | $153,734 | $162,665 | $171,141 | $93,560 | $55,025 |
| Non-Current Assets | |||||
| PPE Net | 212 | 200 | 85 | 81 | 69 |
| Other Non-Current Assets | 78 | 78 | 78 | 1,680 | 127 |
| TOTAL | $290 | $278 | $163 | $1,761 | $196 |
| Total Assets | $154,024 | $162,943 | $171,304 | $95,321 | $55,221 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,022 | 1,271 | 434 | 556 | 908 |
| Accrued Expenses | 4,180 | 5,082 | 2,902 | 3,374 | 3,672 |
| TOTAL | $6,202 | $6,353 | $3,336 | $3,930 | $4,580 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 611 | 284 | 363 | 0 | 0 |
| TOTAL | $611 | $382 | $417 | $32 | $36 |
| Total Liabilities | $6,813 | $6,735 | $3,753 | $3,962 | $4,616 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,446 | 2,442 | 2,441 | 2,429 | N/A |
| Common Shares | 3 | 3 | 3 | N/A | N/A |
| Retained earnings | -84,728 | -74,121 | -61,386 | -52,170 | -44,958 |
| Other shareholders' equity | 34 | 17 | 5 | 140,076 | 92,720 |
| TOTAL | $147,211 | $156,208 | $167,551 | $91,359 | $50,605 |
| Total Liabilities And Equity | $154,024 | $162,943 | $171,304 | $95,321 | $55,221 |